Results: 240 clinical trials
This study is being done to look at whether an agent that is commonly used to treat diabetes, Metformin, can decrease or affect the ability of breast cancer cells to grow and whether Metformin will work with another therapy to keep cancer from returning (recurring).
Contact: Patricia Devore devore@uthscsa.edu (210) 450-1233The main purpose of this study is to evaluate the anti-tumor activity of NKTR-214 in combination with nivolumab by assessing the objective response rate (ORR) in cisplatin ineligible, locally advanced or metastatic urothelial cancer patients with low PD-L1 expression. The efficacy will be assessed within the experimental Arm A, while Arm B will serve as a reference arm.
Contact: Juan Tavera juan.tavera@va.gov 210-617-5300